2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Classical Hodgkin Lymphoma: Does Pembrolizumab Improve PFS vs. Brentuximab Vedotin in Patients With Relapsed/Refractory Disease?

140 views
August 6, 2020
Comments 0
Login to view comments. Click here to Login